Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Genzyme Europe B.V., Paasheuvelweg 25, 1105 BP, Amsterdam, The Netherlands
Thymoglobuline 25 mg powder for solution for infusion.
| Pharmaceutical Form |
|---|
|
Powder for solution for infusion. |
Rabbit anti-human thymocyte immunoglobulin 25 mg per vial. 1 ml reconstituted solution contains 5 mg rabbit, anti-human thymocyte immunoglobulin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin is a selective immunosuppressive agent mostly acting on T lymphocytes. Antithymocyte immunoglobulin is used for the prevention and treatment of graft rejection after solid organ transplantation, usually in combination with other immunosuppressive drugs. |
| List of Excipients |
|---|
|
Glycine Other components: Thymoglobuline may also contain residues of polysorbate, from the manufacturing process. |
Powder in a vial (type I glass) closed with a stopper (chlorobutyl). Each pack contains one 10 ml vial.
Genzyme Europe B.V., Paasheuvelweg 25, 1105 BP, Amsterdam, The Netherlands
PL 12375/0021
18/03/2013
| Drug | Countries | |
|---|---|---|
| THYMOGLOBULINE | Brazil, Ecuador, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Poland, Singapore, Tunisia, Turkey, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
